Clozapine in idiopathic parkinson’s disease: Reply from the authors

Neurology

Volumn 40, Issue 7, 1990, Pages 1151-1152

  Friedman, Joseph H ^a   Lannon, Margaret C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; LEVODOPA; DIBENZAZEPINE DERIVATIVE;

HUMAN; LETTER; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOSIS; TREMOR; NOTE;

CLOZAPINE; DIBENZAZEPINES; HUMAN; PARKINSON DISEASE;

EID: 0025455585     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.40.7.1151     Document Type: Letter

References (6)

1. Friedman JH, Lannon MC. Clozapine in the treatment of psychosis in Parkinson’s disease. Neurology 1989;39:1219-1221.
2. Ungersted U, Ljungberg T. Behavioral patterns related to dopamine neurotransmission: effect of acute and chronic antipsychotic drugs. In: Costa E, Gessa GL, eds. Advances in biochemical psychopharmacology, vol 16. New York: Raven Press, 1977:193-199.
3. Ekblom B, Eriksson K, Lindstrgm LH. Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal. Psychopharmacology (Berlin) 1984;83:293-294.
4. Friedman JH, Lannon MC. Clozapine in the treatment of resting tremor in Parkinson’s disease. Movement Dis (in press).
5. Ostergaard K, Dupont E. Clozapine treatment of drug induced psychotic symptoms in the late stages of Parkinson’s disease. Acta Neural Scand 1988;78:349-350.
6. Pfeiffer RF, Kang J, Graber B, et al. Clozapine for psychosis in Parkinson’s disease. Movement Dis (in press).